跳至主要内容
临床试验/NCT02196116
NCT02196116Unknown不适用

Amyloïd Load in Elderly Population: Effect of Cognitive Reserve

University Hospital, Bordeaux2 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2014年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
120
试验地点
2
主要终点
Amyloid load

研究概览

简要总结

This research aim to explore relationships between the presence of amyloid burden and cognitive performance, and its modulation by educational level. For this purpose we will combine Positron emission tomography (PET) imaging and neuropsychological assessment acquired on 3 groups of subjects, from two population-based cohorts "3C" and "AMIMage" The first group includes cognitively intact participants who will serve as controls, the second group, subjects with mild cognitive impairments without memory complaint and the third, subjects with both mild cognitive impairments and memory complaint.

详细描述

Influence of educational level on the relationship between disease-specific lesion development and cognitive function will be assessed, as measured by amyloid PET imaging and a battery of neuropsychological tests at the very early stages of the disease, comparatively to age-matched controls. In addition, this project will explore the influence of cognitive complaint.

It's assumed that 1) the amyloid-PET measures in age-matched controls and subjects from the two cohorts will correlate with cognitive performances; 2) the amyloid burden will be higher in high- than in low-educated subjects with similar cognitive impairment; and 3) similarly the amyloid burden will be higher in subjects with cognitive complaint compared to subjects without cognitive complaint.

Considering a longer term, the clinical follow-up of study participants will allow to investigate the prognosis value of amyloid load for improving the prediction of cognitive decline and disease progression.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
盲法
None

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participation in the AMI or 3C cohorts Group 1- Controls
  • MMSE > 24 or > 26 for low and high levels of education, respectively.
  • Without memory impairment (for episodic memory) on the Free and Cued Selective Reminding Test RL/RI-16 items (FCSRT), free recall > 22 and total recall >42, according to the thresholds for population-based studies
  • Without memory complaint
  • Without dementia Group 2- Cognitively-impaired subjects without dementia and without memory complaints
  • Mini Mental State Evaluation (MMSE) < 24 or < 26 for low and high levels of education, respectively
  • With memory impairments according to the RL/RI-16 test (free recall≤22 and/or total recall ≤42), according to the thresholds for population-based studies defined by Auriacombe et al.,
  • Without memory complaint
  • Without dementia Group 3- Cognitively-impaired subjects without dementia and with memory complaints
  • MMSE < 24 or < 26 for low and high levels of education, respectively
  • With memory impairments according to the RL/RI-16 test (same thresholds as above)
  • With memory complaint
  • Without dementia

排除标准

  • Being left handed
  • Presence of dementia (based on the clinical diagnosis)
  • Presence of stroke
  • Presence of Parkinson's disease
  • Presence of a counter-indication for MRI
  • Presence of a counter-indication for PET Scan with [18F]-Flutemetamol
  • Presence of any health problem preventing travel to the imaging service of the University Hospital
  • Being under the legal guardianship of another person or being unable to provide consent to participate
  • Pregnant or breastfeeding woman

研究组 & 干预措施

Group 3

Experimental

Cognitively-impaired subjects without dementia and with memory

干预措施: neuropsychological tests (Other)

Group 3

Experimental

Cognitively-impaired subjects without dementia and with memory

干预措施: PET (Other)

Group 3

Experimental

Cognitively-impaired subjects without dementia and with memory

干预措施: MRI (Other)

Group 2

Experimental

Cognitively-impaired subjects without dementia and without memory

干预措施: PET (Other)

Group 2

Experimental

Cognitively-impaired subjects without dementia and without memory

干预措施: MRI (Other)

Group 2

Experimental

Cognitively-impaired subjects without dementia and without memory

干预措施: neuropsychological tests (Other)

Group 1

Active Comparator

Controls

干预措施: MRI (Other)

Group 1

Active Comparator

Controls

干预措施: neuropsychological tests (Other)

Group 1

Active Comparator

Controls

干预措施: PET (Other)

结局指标

主要结局

Amyloid load

时间窗: at inclusion (day 0)

次要结局

  • Neuropsychological scores(At inclusion (Day 0))
  • Educational level(At inclusion (Day 0))
  • Memory complaint(At inclusion (Day 0))

研究者

发起方
University Hospital, Bordeaux
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验